The good news on that front according to today's announcement is that won't be the case...
"Trial enrolment will not be halted during each planned DSMB review of the safety data."
Ann: Phase 2 Stroke Clinical Trial Update, page-21
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
72.0¢ |
Change
0.030(4.35%) |
Mkt cap ! $92.22M | |||
| Open | High | Low | Value | Volume |
| 70.0¢ | 72.5¢ | 70.0¢ | $43.97K | 62.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17447 | 72.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 72.5¢ | 4200 | 1 |
View Market Depth
| Last trade - 14.49pm 04/10/2024 (20 minute delay) ? |
| AGN (ASX) Chart |